Full View

Good Research Practices for Measuring Drug Costs in Cost‐Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report—Part II

LP Garrison Jr, EC Mansley, TA Abbott III… - Value in …, 2010 - Wiley Online Library
Objectives: Major guidelines regarding the application of cost‐effectiveness analysis (CEA)
have recommended the common and widespread use of the “societal perspective” for …
被引用次数：162 相关文章

Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report—Part II

LP Garrison, EC Mansley, TA Abbott, BW Bresnahan… - Value in Health, 2010 - infona.pl
Major guidelines regarding the application of cost-effectiveness analysis (CEA) have
recommended the common and widespread use of the “societal perspective” for purposes of …

Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report—Part II.

LP Garrison Jr, EC Mansley, TA Abbott III… - Value in …, 2010 - search.ebscohost.com
Objectives: Major guidelines regarding the application of cost-effectiveness analysis (CEA)
have recommended the common and widespread use of the “societal perspective” for …

Good research practices for measuring drug costs in cost-effectiveness analyses: a societal perspective: the ISPOR Drug Cost Task Force report--Part II

LP Garrison Jr, EC Mansley… - Value in health: the …, 2010 - pubmed.ncbi.nlm.nih.gov
Objectives Major guidelines regarding the application of cost-effectiveness analysis (CEA)
have recommended the common and widespread use of the" societal perspective" for …

Good research practices for measuring drug costs in cost-effectiveness analyses: a societal perspective: the ISPOR Drug Cost Task Force report--Part II.

LP Garrison Jr, EC Mansley, TA Abbott 3rd… - Value in Health: the …, 2009 - europepmc.org
Objectives Major guidelines regarding the application of cost-effectiveness analysis (CEA)
have recommended the common and widespread use of the" societal perspective" for …

[引用][C] Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report—Part II

LP Garrison, EC Mansley, TA Abbott, BW Bresnahan… - Value in Health, 2010 - cir.nii.ac.jp
Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal
Perspective: The ISPOR Drug Cost Task Force Report—Part II | CiNii Research CiNii 国立 …

Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report—Part II

LP Garrison, EC Mansley, TA Abbott… - Value in …, 2010 - valueinhealthjournal.com
Objectives Major guidelines regarding the application of cost-effectiveness analysis (CEA)
have recommended the common and widespread use of the" societal perspective" for …
[HTML] sciencedirect.com

[HTML][HTML] Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report—Part II

LP Garrison Jr, EC Mansley, TA Abbott III… - Value in Health, 2010 - Elsevier
OBJECTIVES: Major guidelines regarding the application of cost-effectiveness analysis
(CEA) have recommended the common and widespread use of the “societal perspective” for …

Good Research Practices for Measuring Drug Costs in Cost‐Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report—Part II

LP Garrison, EC Mansley, TA Abbott, BW Bresnahan… - Value in Health, 2009 - infona.pl
Objectives: Major guidelines regarding the application of cost‐effectiveness analysis (CEA)
have recommended the common and widespread use of the “societal perspective” for …

[引用][C] Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report—Part II

LP GARRISON, EC MANSLEY, TA ABBOTT… - Value in health, 2010 - Elsevier